Basic Information
| LncRNA/CircRNA Name | SNHG3 |
| Synonyms | NA |
| Region | GRCh38_1:28505980-28510892 |
| Ensemble | ENSG00000242125 |
| Refseq | NR_002909.1 |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | osteosarcoma |
| ICD-0-3 | NA |
| Methods | qPCR, Luciferase reporter assay, Western blot |
| Sample | OS tissue,cell lines (MG-63, 143B, HOS, SW-1353, Saos-2, U-2OS) |
| Expression Pattern | up-regulated |
| Function Description | As a result, the expression of SNHG3 was dramatically increased in OS tissue as compared with the adjacent normal tissues. |
| Pubmed ID | 30791797 |
| Year | 2019 |
| Title | LncRNA SNHG3 promotes cell growth by sponging miR-196a-5p and indicates the poor survival in osteosarcoma. |
External Links
| Links for SNHG3 | GenBank HGNC NONCODE |
| Links for osteosarcoma | OMIM COSMIC |